Supervivencia de pacientes COVID-19 con tratamiento por IECA y ARA-II vs pacientes sin medicación previa

Supervivencia de pacientes COVID-19 con tratamiento por IECA y ARA-II vs pacientes sin medicación previa

ABSTRACT Introduction: COVID-19 is a new disease declared a pandemic on March 11, 2020, by the WHO. This disease is caused by the SARS-CoV-2 coronavirus that enters host cells using ACE-2 as a receptor. Objective: This project aims to determine the survival rate at the discharge of geriatric patient...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Hovedforfatter: Sofía Anabel, Alulema Domínguez (author)
Andre forfattere: Camila Alejandra, Pérez Romo (author)
Format: bachelorThesis
Udgivet: 2021
Fag:
COVID-19
SARS-CoV-2
ACE2
ARA-II
Online adgang:http://dspace.unach.edu.ec/handle/51000/7565
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Internet

http://dspace.unach.edu.ec/handle/51000/7565

Lignende værker